Thomas Jefferson University

Eric Michelson

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentFaculty Records and Publicatio - Thomas Jefferson University
Address833 Chestnut Street
Philadelphia PA 19023
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    K08HL001312     (MICHELSON, ERIC L)Aug 1, 1983 - Nov 30, 1988
    NIH
    EXPERIMENTAL VENTRICULAR TACHYARRHYTHMIAS
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Samsky M, Krucoff M, Althouse AD, Abraham WT, Adamson P, Aguel F, Bilazarian S, Dangas GD, Gilchrist IC, Henry TD, Hochman JS, Kapur NK, Laschinger J, Masters RG, Michelson E, Morrow DA, Morrow V, Ohman EM, Pina I, Proudfoot AG, Rogers J, Sapirstein J, Senatore F, Stockbridge N, Thiele H, Truesdell AG, Waksman R, Rao S. Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock. Am Heart J. 2020 01; 219:1-8. PMID: 31707323.
      Citations:    
    2. Aziz PF, Berger S, Kowey P, Krucoff M, Lopez-Anderson M, Michelson E, Molossi S, Morrow V, Rodriguez I, Saarel TE, Strnadova C, Vetter V, Wright TJ, Idriss SF. The Second Annual Think Tank on Prevention of Sudden Cardiac Death in the Young: Developing a rational, reliable, and sustainable national health care resource. A report from the Cardiac Safety Research Consortium. Am Heart J. 2018 08; 202:104-108. PMID: 29920452.
      Citations:    
    3. Bui AH, Cannon CP, Steg PG, Storey RF, Husted S, Guo J, Im K, James SK, Michelson EL, Himmelmann A, Held C, Varenhorst C, Wallentin L, Scirica BM. Relationship Between Early and Late Nonsustained Ventricular Tachycardia and Cardiovascular Death in Patients With Acute Coronary Syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) Trial. Circ Arrhythm Electrophysiol. 2016 Feb; 9(2):e002951. PMID: 26810596.
      Citations:    
    4. Sabol ME, Finkle J, Krucoff M, Stockbridge N, Parkhill N, Shinagawa K, Mahaffey K, Tcheng J, Lenihan D, Melloni C, Todaro T, Michelson E, Munley J, Zander J, Oh R. Cardiac Safety Research Consortium (CSRC): Cardiovascular Safety and Adverse Event Case Report Forms. Ther Innov Regul Sci. 2015 Jul; 49(4):511-513. PMID: 30222439.
      Citations:    
    5. Heller S, Darp? B, Mitchell MI, Linnebjerg H, Leishman DJ, Mehrotra N, Zhu H, Koerner J, Fiszman ML, Balakrishnan S, Xiao S, Todaro TG, Hensley I, Guth BD, Michelson EL, Sager P. Considerations for assessing the potential effects of antidiabetes drugs on cardiac ventricular repolarization: A report from the Cardiac Safety Research Consortium. Am Heart J. 2015 Jul; 170(1):23-35. PMID: 26093861.
      Citations:    
    6. Rogers JK, Pocock SJ, McMurray JJ, Granger CB, Michelson EL, ?stergren J, Pfeffer MA, Solomon SD, Swedberg K, Yusuf S. Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved. Eur J Heart Fail. 2014 Jan; 16(1):33-40. PMID: 24453096.
      Citations:    
    7. Nada A, Gintant GA, Kleiman R, Gutstein DE, Gottfridsson C, Michelson EL, Strnadova C, Killeen M, Geiger MJ, Fiszman ML, Koplowitz LP, Carlson GF, Rodriguez I, Sager PT. The evaluation and management of drug effects on cardiac conduction (PR and QRS intervals) in clinical development. Am Heart J. 2013 Apr; 165(4):489-500. PMID: 23537964.
      Citations:    
    8. Sager P, Heilbraun J, Turner JR, Gintant G, Geiger MJ, Kowey PR, Mansoor GA, Mendzelevski B, Michelson EL, Stockbridge N, Weber MA, White WB. Assessment of drug-induced increases in blood pressure during drug development: report from the Cardiac Safety Research Consortium. Am Heart J. 2013 Apr; 165(4):477-88. PMID: 23537963.
      Citations:    
    9. Christian JB, Finkle JK, Ky B, Douglas PS, Gutstein DE, Hockings PD, Lainee P, Lenihan DJ, Mason JW, Sager PT, Todaro TG, Hicks KA, Kane RC, Ko HS, Lindenfeld J, Michelson EL, Milligan J, Munley JY, Raichlen JS, Shahlaee A, Strnadova C, Ye B, Turner JR. Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction. Am Heart J. 2012 Dec; 164(6):846-55. PMID: 23194484.
      Citations:    
    10. Castagno D, Skali H, Takeuchi M, Swedberg K, Yusuf S, Granger CB, Michelson EL, Pfeffer MA, McMurray JJ, Solomon SD. Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program. J Am Coll Cardiol. 2012 May 15; 59(20):1785-95. PMID: 22575317.
      Citations:    
    11. Ariti CA, Cleland JG, Pocock SJ, Pfeffer MA, Swedberg K, Granger CB, McMurray JJ, Michelson EL, Ostergren J, Yusuf S. Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Am Heart J. 2011 Nov; 162(5):900-6. PMID: 22093207.
      Citations:    
    12. Scirica BM, Cannon CP, Emanuelsson H, Michelson EL, Harrington RA, Husted S, James S, Katus H, Pais P, Raev D, Spinar J, Steg PG, Storey RF, Wallentin L. The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy. J Am Coll Cardiol. 2011 May 10; 57(19):1908-16. PMID: 21545948.
      Citations:    
    13. Chang SM, Granger CB, Johansson PA, Kosolcharoen P, McMurray JJ, Michelson EL, Murray DR, Olofsson B, Pfeffer MA, Solomon SD, Swedberg K, Yusuf S, Dunlap ME. Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur J Heart Fail. 2010 Jul; 12(7):738-45. PMID: 20418272.
      Citations:    
    14. Hawkins NM, Wang D, Petrie MC, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Solomon SD, Ostergren J, Michelson EL, Pocock SJ, Maggioni AP, McMurray JJ. Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme. Eur J Heart Fail. 2010 Jun; 12(6):557-65. PMID: 20356870.
      Citations:    
    15. Granger BB, Ekman I, Granger CB, Ostergren J, Olofsson B, Michelson E, McMurray JJ, Yusuf S, Pfeffer MA, Swedberg K. Adherence to medication according to sex and age in the CHARM programme. Eur J Heart Fail. 2009 Nov; 11(11):1092-8. PMID: 19875409.
      Citations:    
    16. Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, Granger CB, Swedberg K, Pfeffer MA, Yusuf S, McMurray JJ. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet. 2009 Aug 15; 374(9689):543-50. PMID: 19683640.
      Citations:    
    17. Preiss D, Zetterstrand S, McMurray JJ, Ostergren J, Michelson EL, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, Gerstein HC, Sattar N. Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program. Diabetes Care. 2009 May; 32(5):915-20. PMID: 19196892.
      Citations:    
    18. Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail. 2009 Feb; 11(2):170-7. PMID: 19168515.
      Citations:    
    19. Meredith PA, Ostergren J, Anand I, Puu M, Solomon SD, Michelson EL, Olofsson B, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, McMurray JJ. Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program. J Am Coll Cardiol. 2008 Dec 09; 52(24):2000-7. PMID: 19055992.
      Citations:    
    20. Syed Z, Scirica BM, Mohanavelu S, Sung P, Michelson EL, Cannon CP, Stone PH, Stultz CM, Guttag JV. Relation of death within 90 days of non-ST-elevation acute coronary syndromes to variability in electrocardiographic morphology. Am J Cardiol. 2009 Feb 01; 103(3):307-11. PMID: 19166680.
      Citations:    
    21. Abrahamsson P, Dobson J, Granger CB, McMurray JJ, Michelson EL, Pfeffer M, Pocock S, Solomon SD, Yusuf S, Swedberg K. Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure. Eur Heart J. 2009 Feb; 30(3):338-45. PMID: 19001475.
      Citations:    
    22. Cohen-Solal A, McMurray JJ, Swedberg K, Pfeffer MA, Puu M, Solomon SD, Michelson EL, Yusuf S, Granger CB. Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programme. Eur Heart J. 2008 Dec; 29(24):3022-8. PMID: 18987098.
      Citations:    
    23. Pocock SJ, McMurray JJ, Dobson J, Yusuf S, Granger CB, Michelson EL, Ostergren J, Pfeffer MA, Solomon SD, Anker SD, Swedberg KB. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J. 2008 Nov; 29(21):2641-50. PMID: 18819960.
      Citations:    
    24. Gerstein HC, Swedberg K, Carlsson J, McMurray JJ, Michelson EL, Olofsson B, Pfeffer MA, Yusuf S. The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Arch Intern Med. 2008 Aug 11; 168(15):1699-704. PMID: 18695086.
      Citations:    
    25. Williams SA, Michelson EL, Cain VA, Yang M, Nesbitt SD, Egan BM, Julius S. An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension (TROPHY). J Clin Hypertens (Greenwich). 2008 Jun; 10(6):436-42. PMID: 18550933.
      Citations:    
    26. MacDonald MR, Petrie MC, Varyani F, Ostergren J, Michelson EL, Young JB, Solomon SD, Granger CB, Swedberg K, Yusuf S, Pfeffer MA, McMurray JJ. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur Heart J. 2008 Jun; 29(11):1377-85. PMID: 18413309.
      Citations:    
    27. Weir RA, McMurray JJ, Puu M, Solomon SD, Olofsson B, Granger CB, Yusuf S, Michelson EL, Swedberg K, Pfeffer MA. Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial. Eur J Heart Fail. 2008 Feb; 10(2):157-63. PMID: 18242128.
      Citations:    
    28. Julius S, Kaciroti N, Egan BM, Nesbitt S, Michelson EL. TROPHY study: Outcomes based on the Seventh Report of the Joint National Committee on Hypertension definition of hypertension. J Am Soc Hypertens. 2008 Jan-Feb; 2(1):39-43. PMID: 20409883.
      Citations:    
    29. Desai AS, Swedberg K, McMurray JJ, Granger CB, Yusuf S, Young JB, Dunlap ME, Solomon SD, Hainer JW, Olofsson B, Michelson EL, Pfeffer MA. Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program. J Am Coll Cardiol. 2007 Nov 13; 50(20):1959-66. PMID: 17996561.
      Citations:    
    30. Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation. 2007 Sep 25; 116(13):1482-7. PMID: 17724259.
      Citations:    
    31. Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, Granger CB, McMurray JJ, Solomon SD. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2007 Aug 07; 116(6):627-36. PMID: 17638930.
      Citations:    
    32. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007 Jul 03; 50(1):40-7. PMID: 17601544.
      Citations:    
    33. O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Pi?a IL, Granger CB, Ostergren J, Michelson EL, Solomon SD, Pocock S, Yusuf S, Swedberg K, Pfeffer MA. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2007 Jun 19; 115(24):3111-20. PMID: 17562950.
      Citations:    
    34. Hawkins NM, Wang D, McMurray JJ, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Pocock SJ, Ostergren J, Michelson EL, Dunn FG. Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme. Eur J Heart Fail. 2007 May; 9(5):510-7. PMID: 17317308.
      Citations:    
    35. Lewis EF, Lamas GA, O'Meara E, Granger CB, Dunlap ME, McKelvie RS, Probstfield JL, Young JB, Michelson EL, Halling K, Carlsson J, Olofsson B, McMurray JJ, Yusuf S, Swedberg K, Pfeffer MA. Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. Eur J Heart Fail. 2007 Jan; 9(1):83-91. PMID: 17188020.
      Citations:    
    36. Hawkins NM, Wang D, McMurray JJ, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Pocock SJ, Ostergren J, Michelson EL, Dunn FG. Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme. Heart. 2007 Jan; 93(1):59-64. PMID: 16952975.
      Citations:    
    37. Ducharme A, Swedberg K, Pfeffer MA, Cohen-Solal A, Granger CB, Maggioni AP, Michelson EL, McMurray JJ, Olsson L, Rouleau JL, Young JB, Olofsson B, Puu M, Yusuf S. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Am Heart J. 2006 Jul; 152(1):86-92. PMID: 16838426.
      Citations:    
    38. McMurray JJ, Young JB, Dunlap ME, Granger CB, Hainer J, Michelson EL, Earle S, Olofsson B, Ostergren J, Yusuf S, Swedberg K, Pfeffer MA. Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial. Am Heart J. 2006 May; 151(5):985-91. PMID: 16644319.
      Citations:    
    39. Ducharme A, Swedberg K, Pfeffer MA, Cohen-Solal A, Granger CB, Maggioni AP, Michelson EL, McMurray JJ, Olsson L, Rouleau JL, Young JB, Yusuf S. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program. Am Heart J. 2006 May; 151(5):985-91. PMID: 16644318.
      Citations:    
    40. Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, Puu M, Yusuf S, Pfeffer MA. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol. 2006 May 16; 47(10):1997-2004. PMID: 16697316.
      Citations:    
    41. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, Black HR, Grimm RH, Messerli FH, Oparil S, Schork MA. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006 Apr 20; 354(16):1685-97. PMID: 16537662.
      Citations:    
    42. O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Lang CC, Roger SD, Young JB, Solomon SD, Granger CB, Ostergren J, Olofsson B, Michelson EL, Pocock S, Yusuf S, Swedberg K, Pfeffer MA. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation. 2006 Feb 21; 113(7):986-94. PMID: 16476847.
      Citations:    
    43. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de Zeeuw D, Pocock S, van Veldhuisen DJ. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006 Feb 07; 113(5):671-8. PMID: 16461840.
      Citations:    
    44. Granger BB, Swedberg K, Ekman I, Granger CB, Olofsson B, McMurray JJ, Yusuf S, Michelson EL, Pfeffer MA. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet. 2005 Dec 10; 366(9502):2005-11. PMID: 16338449.
      Citations:    
    45. Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, Pfeffer MA. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005 Dec 13; 112(24):3738-44. PMID: 16330684.
      Citations:    
    46. Demers C, McMurray JJ, Swedberg K, Pfeffer MA, Granger CB, Olofsson B, McKelvie RS, Ostergren J, Michelson EL, Johansson PA, Wang D, Yusuf S. Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure. JAMA. 2005 Oct 12; 294(14):1794-8. PMID: 16219883.
      Citations:    
    47. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, Ostergren J, Michelson EL, Pieper KS, Granger CB. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J. 2006 Jan; 27(1):65-75. PMID: 16219658.
      Citations:    
    48. O'Meara E, Lewis E, Granger C, Dunlap ME, McKelvie RS, Probstfield JL, Young JB, Michelson EL, Ostergren J, Carlsson J, Olofsson B, McMurray J, Yusuf S, Swedberg K, Pfeffer MA. Patient perception of the effect of treatment with candesartan in heart failure. Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur J Heart Fail. 2005 Jun; 7(4):650-6. PMID: 15921807.
      Citations:    
    49. Egan BM, Papademetriou V, Wofford M, Calhoun D, Fernandes J, Riehle JE, Nesbitt S, Michelson E, Julius S. Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure. Am J Hypertens. 2005 Jan; 18(1):3-12. PMID: 15691610.
      Citations:    
    50. O'Meara E, Solomon S, McMurray J, Pfeffer M, Yusuf S, Michelson E, Granger C, Olofsson B, Young JB, Swedberg K. Effect of candesartan on New York Heart Association functional class. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur Heart J. 2004 Nov; 25(21):1920-6. PMID: 15522471.
      Citations:    
    51. Young JB, Dunlap ME, Pfeffer MA, Probstfield JL, Cohen-Solal A, Dietz R, Granger CB, Hradec J, Kuch J, McKelvie RS, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Held P, Solomon SD, Yusuf S, Swedberg K. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials. Circulation. 2004 Oct 26; 110(17):2618-26. PMID: 15492298.
      Citations:    
    52. Solomon SD, Wang D, Finn P, Skali H, Zornoff L, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Pocock S, Pfeffer MA. Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2004 Oct 12; 110(15):2180-3. PMID: 15466644.
      Citations:    
    53. Julius S, Nesbitt S, Egan B, Kaciroti N, Schork MA, Grozinski M, Michelson E. Trial of preventing hypertension: design and 2-year progress report. Hypertension. 2004 Aug; 44(2):146-51. PMID: 15238567.
      Citations:    
    54. Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet. 2003 Sep 06; 362(9386):772-6. PMID: 13678870.
      Citations:    
    55. McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet. 2003 Sep 06; 362(9386):767-71. PMID: 13678869.
      Citations:    
    56. Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003 Sep 06; 362(9386):759-66. PMID: 13678868.
      Citations:    
    57. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003 Sep 06; 362(9386):777-81. PMID: 13678871.
      Citations:    
    58. McMurray J, Ostergren J, Pfeffer M, Swedberg K, Granger C, Yusuf S, Held P, Michelson E, Olofsson B. Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur J Heart Fail. 2003 Jun; 5(3):261-70. PMID: 12798823.
      Citations:    
    59. Pepine CJ, Cooper-DeHoff RM, Weiss RJ, Koren M, Bittar N, Thadani U, Minkwitz MC, Michelson EL, Hutchinson HG. Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris. Am J Cardiol. 2003 Feb 01; 91(3):274-9. PMID: 12565082.
      Citations:    
    60. Haider AW, Wilson PW, Larson MG, Evans JC, Michelson EL, Wolf PA, O'Donnell CJ, Levy D. The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study. J Am Coll Cardiol. 2002 Oct 16; 40(8):1408-13. PMID: 12392829.
      Citations:    
    61. Vidt DG, White WB, Ridley E, Rahman M, Harris S, Vendetti J, Michelson EL, Wang R. A forced titration study of antihypertensive efficacy of candesartan cilexetil in comparison to losartan: CLAIM Study II. J Hum Hypertens. 2001 Jul; 15(7):475-80. PMID: 11464257.
      Citations:    
    62. Weir MR, Weber MA, Neutel JM, Vendetti J, Michelson EL, Wang RY. Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy: a clinical experience trial. ACTION Study Investigators. Am J Hypertens. 2001 Jun; 14(6 Pt 1):567-72. PMID: 11411737.
      Citations:    
    63. Kloner RA, Weinberger M, Pool JL, Chrysant SG, Prasad R, Harris SM, Zyczynski TM, Leidy NK, Michelson EL. Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators. Am J Cardiol. 2001 Mar 15; 87(6):727-31. PMID: 11249891.
      Citations:    
    64. Bakris G, Gradman A, Reif M, Wofford M, Munger M, Harris S, Vendetti J, Michelson EL, Wang R. Antihypertensive efficacy of candesartan in comparison to losartan: the CLAIM study. J Clin Hypertens (Greenwich). 2001 Jan-Feb; 3(1):16-21. PMID: 11416677.
      Citations:    
    65. Zyczynski TM, Leidy NK, Kong BW, Helaszek CT, Michelson EL. Effects of candesartan cilexetil on health-related quality of life in black patients with systemic hypertension in the ABC Trial. Heart Dis. 2000 Nov-Dec; 2(6):400-6. PMID: 11728290.
      Citations:    
    66. Roy-Byrne PP, Katon W, Cowley DS, Russo JE, Cohen E, Michelson E, Parrot T. Panic disorder in primary care: biopsychosocial differences between recognized and unrecognized patients. Gen Hosp Psychiatry. 2000 Nov-Dec; 22(6):405-11. PMID: 11072056.
      Citations:    
    67. Shah MR, Granger CB, Bart BA, McMurray JJ, Petrie MC, Michelson EL, Tudor GE, Swedberg K, Stevenson LW, Califf RM, Pfeffer MA. Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry. Am J Med. 2000 Oct 15; 109(6):489-92. PMID: 11042239.
      Citations:    
    68. Neutel JM, Weir MR, Moser M, Harris S, Edwards D, Michelson EL, Wang R. The Effects of Candesartan Cilexetil in Isolated Systolic Hypertension: A Clinical Experience Trial. J Clin Hypertens (Greenwich). 2000 May; 2(3):181-186. PMID: 11416644.
      Citations:    
    69. Granger CB, Ertl G, Kuch J, Maggioni AP, McMurray J, Rouleau JL, Stevenson LW, Swedberg K, Young J, Yusuf S, Califf RM, Bart BA, Held P, Michelson EL, Sellers MA, Ohlin G, Sparapani R, Pfeffer MA. Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors. Am Heart J. 2000 Apr; 139(4):609-17. PMID: 10740141.
      Citations:    
    70. Bart BA, Ertl G, Held P, Kuch J, Maggioni AP, McMurray J, Michelson EL, Rouleau JL, Warner Stevenson L, Swedberg K, Young JB, Yusuf S, Sellers MA, Granger CB, Califf RM, Pfeffer MA. Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. Eur Heart J. 1999 Aug; 20(16):1182-90. PMID: 10448027.
      Citations:    
    71. Oparil S, Levine JH, Zuschke CA, Gradman AH, Ripley E, Jones DW, Hardison JD, Cushing DJ, Prasad R, Michelson EL. Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators. Am J Cardiol. 1999 Aug 01; 84(3):289-93. PMID: 10496437.
      Citations:    
    72. Gradman AH, Lewin A, Bowling BT, Tonkon M, Deedwania PC, Kezer AE, Hardison JD, Cushing DJ, Michelson EL. Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study Group. Heart Dis. 1999 May-Jun; 1(2):52-7. PMID: 11720604.
      Citations:    
    73. Zuschke CA, Keys I, Munger MA, Carr AA, Marinides GN, Flanagan TL, Cushing DJ, Hayes JL, Michelson EL. Candesartan cilexetil: comparison of once-daily versus twice-daily administration for systemic hypertension. Candesartan Cilexetil Study Investigators. Clin Ther. 1999 Mar; 21(3):464-74. PMID: 10321416.
      Citations:    
    74. Bell TP, DeQuattro V, Lasseter KC, Ruff D, Hardison JD, Cushing D, Kezer AE, Michelson EL. Effective dose range of candesartan cilexetil for systemic hypertension. Candesartan Cilexetil Study Investigators. Am J Cardiol. 1999 Jan 15; 83(2):272-5, A6. PMID: 10073836.
      Citations:    
    75. Reif M, White WB, Fagan TC, Oparil S, Flanagan TL, Edwards DT, Cushing DJ, Michelson EL. Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators. Am J Cardiol. 1998 Oct 15; 82(8):961-5. PMID: 9794352.
      Citations:    
    76. Gradman AH, Cutler NR, Davis PJ, Robbins JA, Weiss RJ, Wood BC, Michelson EL. Long-term efficacy, tolerability, and safety of the combination of enalapril and felodipine ER in the treatment of hypertension. Enalapril-Felodipine ER Factorial Study Group. Clin Ther. 1998 May-Jun; 20(3):527-38. PMID: 9663368.
      Citations:    
    77. Spratt KA, Borans SM, Michelson EL. Early repolarization: normalization of the electrocardiogram with exercise as a clinically useful diagnostic feature. J Invasive Cardiol. 1995 Oct; 7(8):238-42. PMID: 10158115.
      Citations:    
    78. Warnick WC, Ross JJ, Michelson EL. Recognition of mechanical complications of acute myocardial infarction. Compr Ther. 1995 Jul; 21(7):362-6. PMID: 7554813.
      Citations:    
    79. Alpert JS, Arnold WJ, Chaitman BR, Conti CR, Ewy GA, Michelson EL, Myerburg RJ. Guidelines for training in adult cardiovascular medicine. Core Cardiology Training Symposium (COCATS). Task Force 1: training in clinical cardiology. J Am Coll Cardiol. 1995 Jan; 25(1):4-9. PMID: 7798524.
      Citations:    
    80. Goldstein MA, Michelson EL, Dreifus LS. The electrocardiogram in valvular heart disease. Cardiovasc Clin. 1993; 23:55-64. PMID: 8416131.
      Citations:    
    81. Doorey AJ, Michelson EL, Topol EJ. Thrombolytic therapy of acute myocardial infarction. Keeping the unfulfilled promises. JAMA. 1992 Dec 02; 268(21):3108-14. PMID: 1433742.
      Citations:    
    82. Michelson EL. Calcium antagonists in cardiology: update on sustained-release drug delivery systems. Clin Cardiol. 1991 Dec; 14(12):947-50. PMID: 1841019.
      Citations:    
    83. Karalis DG, Nydegger C, Porter RS, Carver J, Pina IL, Kutalek SP, Michelson EL. Effects of encainide and metabolizer phenotype on ventricular conduction during exercise. Am J Cardiol. 1990 Dec 01; 66(19):1393-6. PMID: 2123075.
      Citations:    
    84. Imaizumi S, Mazgalev T, Dreifus LS, Michelson EL, Miyagawa A, Bharati S, Lev M. Morphological and electrophysiological correlates of atrioventricular nodal response to increased vagal activity. Circulation. 1990 Sep; 82(3):951-64. PMID: 2394013.
      Citations:    
    85. Pelleg A, Hurt C, Miyagawa A, Michelson EL, Dreifus LS. Differential sensitivity of cardiac pacemakers to exogenous adenosine in vivo. Am J Physiol. 1990 Jun; 258(6 Pt 2):H1815-22. PMID: 2360671.
      Citations:    
    86. Pelleg A, Hurt CM, Michelson EL. Cardiac effects of adenosine and ATP. Ann N Y Acad Sci. 1990; 603:19-30. PMID: 2291521.
      Citations:    
    87. Schoenberger JA, Wallin JD, Gorwit JI, Davidov ME, Michelson EL, Poland MP, Frishman WH. A multicenter double-blind study of the efficacy and safety of once and twice daily dilevalol compared to propranolol. Am J Hypertens. 1989 Nov; 2(11 Pt 1):840-6. PMID: 2686711.
      Citations:    
    88. Schoenberger JA, Frishman WH, Wallin JD, Gorwit J, Davidov ME, Michelson EL, Bedsole GD, Cubbon J, Poland MP. Dilevalol compared with propranolol and placebo for systemic hypertension. Am J Cardiol. 1989 Jun 05; 63(19):45I-49I. PMID: 2658529.
      Citations:    
    89. Platia EV, Michelson EL, Porterfield JK, Das G. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. Am J Cardiol. 1989 Apr 15; 63(13):925-9. PMID: 2564725.
      Citations:    
    90. Fagan TC, Brown R, Schnaper H, Smolens P, Montijo M, Michelson E, Conrad KA, Lessem J, Freedman D. Nicardipine and hydrochlorothiazide in essential hypertension. Clin Pharmacol Ther. 1989 Apr; 45(4):429-38. PMID: 2649300.
      Citations:    
    91. Pelleg A, Mitamura H, Price R, Kaplinsky E, Menduke H, Dreifus LS, Michelson EL. Extracellular potassium ion dynamics and ventricular arrhythmias in the canine heart. J Am Coll Cardiol. 1989 Mar 15; 13(4):941-50. PMID: 2926046.
      Citations:    
    92. Mazgalev T, Dreifus LS, Michelson EL. A new mechanism for atrioventricular nodal gap-vagal modulation of conduction. Circulation. 1989 Feb; 79(2):417-30. PMID: 2914354.
      Citations:    
    93. Michelson EL, McGeehin FC, Levin BK. Clinical use of sustained-release procainamide in treatment of cardiac arrhythmias. Angiology. 1988 Jul; 39(7 Pt 2):647-54. PMID: 3044199.
      Citations:    
    94. Schwartz M, Michelson EL, Sawin HS, MacVaugh H. Esmolol: safety and efficacy in postoperative cardiothoracic patients with supraventricular tachyarrhythmias. Chest. 1988 Apr; 93(4):705-11. PMID: 2894920.
      Citations:    
    95. Michelson EL, Dreifus LS. Newer antiarrhythmic drugs. Med Clin North Am. 1988 Mar; 72(2):275-319. PMID: 3279283.
      Citations:    
    96. David D, Michelson EL, Naito M, Dreifus LS. Extracellular potassium dynamics in the border zone during acute myocardial ischemia in a canine model. J Am Coll Cardiol. 1988 Feb; 11(2):422-30. PMID: 3339183.
      Citations:    
    97. Hanich RF, de Langen CD, Kadish AH, Michelson EL, Levine JH, Spear JF, Moore EN. Inducible sustained ventricular tachycardia 4 years after experimental canine myocardial infarction: electrophysiologic and anatomic comparisons with early healed infarcts. Circulation. 1988 Feb; 77(2):445-56. PMID: 3338134.
      Citations:    
    98. de Langen CD, Hanich RF, Michelson EL, Kadish AH, Levine JH, Balke CW, Spear JF, Moore EN. Differential effects of procainamide, lidocaine and acetylstrophanthidin on body surface potentials and epicardial conduction in dogs with chronic myocardial infarction. J Am Coll Cardiol. 1988 Feb; 11(2):403-13. PMID: 3339181.
      Citations:    
    99. David D, Michelson EL, Dreifus LS. Public health aspects and optimal systems for ambulatory care. Cardiovasc Clin. 1988; 18(3):1-4. PMID: 3359468.
      Citations:    
    100. Pelleg A, Miyagawa A, Michelson EL, Dreifus LS. On the mechanisms of cardiac electrophysiologic actions of adenosine and adenosine 5'-triphosphate. Prog Clin Biol Res. 1988; 275:225-37. PMID: 3051010.
      Citations:    
    101. David D, Michelson EL. Transtelephonic electrocardiographic monitoring for the detection and treatment of cardiac arrhythmias. Cardiovasc Clin. 1988; 18(3):73-82. PMID: 3282668.
      Citations:    
    102. Mazgalev T, Miyagawa A, Dreifus LS, Michelson EL. Vagal control of the atrioventricular node--in vitro observations. II. Differential postganglionic vagal influence on anterograde atrioventricular nodal conduction and junctional pacemaker activity. Prog Clin Biol Res. 1988; 275:155-67. PMID: 3174671.
      Citations:    
    103. Dreifus LS, Mazgalev T, Miyagawa A, Michelson EL. Modulation of the effects of postganglionic vagal stimulation in the sinus and atrioventricular nodes by cardioactive agents and electrolytes. Prog Clin Biol Res. 1988; 275:207-23. PMID: 3174672.
      Citations:    
    104. Mazgalev T, Dreifus LS, Michelson EL. Vagal control of the atrioventricular node--in vitro observations. I. Electrophysiological mechanism underlying the effects of brief vagal discharges on atrioventricular nodal conduction. Prog Clin Biol Res. 1988; 275:133-54. PMID: 3174670.
      Citations:    
    105. Pelleg A, Mitsuoka T, Mazgalev T, Michelson EL. Interacting negative chronotropic effects of adenosine and the vagus nerve on the canine sinus node. Cardiovasc Res. 1988 Jan; 22(1):55-61. PMID: 3167928.
      Citations:    
    106. Doorey AJ, Michelson EL, Weber FJ, Dreifus LS. Thrombolytic therapy of acute myocardial infarction: emerging challenges of implementation. J Am Coll Cardiol. 1987 Dec; 10(6):1357-60. PMID: 3680805.
      Citations:    
    107. Mitsuoka T, Mazgalev T, Dreifus LS, Michelson EL. Differential vagal effects on antegrade vs. retrograde atrioventricular conduction. Am J Physiol. 1987 Nov; 253(5 Pt 2):H1059-68. PMID: 3688250.
      Citations:    
    108. Mitsuoka T, Pelleg A, Michelson EL, Dreifus LS. Canine AV nodal artery: anatomical variations and a detailed description of cannulation technique. Am J Physiol. 1987 Oct; 253(4 Pt 2):H968-73. PMID: 3661745.
      Citations:    
    109. Pelleg A, Mitsuoka T, Michelson EL, Menduke H. Adenosine mediates the negative chronotropic action of adenosine 5'-triphosphate in the canine sinus node. J Pharmacol Exp Ther. 1987 Sep; 242(3):791-5. PMID: 3656114.
      Citations:    
    110. Pelleg A, Michelson EL. Role of the vagus in modulation by Ca2+ of the depressant action of adenosine and adenosine 5'-triphosphate on the canine sinus node in vivo. J Auton Pharmacol. 1987 Jun; 7(2):127-34. PMID: 3654681.
      Citations:    
    111. Ohm OJ, Mitamura H, Michelson EL, Sauermelch C, Dreifus LS. Ventricular tachyarrhythmia initiation in a canine model of recent myocardial infarction. Comparison of unipolar cathodal, anodal and bipolar stimulation. Cardiology. 1987; 74(3):169-81. PMID: 3594506.
      Citations:    
    112. Mazgalev T, Dreifus LS, Michelson EL, Pelleg A. Adenosine-vagus interaction at the cellular level. Prog Clin Biol Res. 1987; 230:195-219. PMID: 3588597.
      Citations:    
    113. Pelleg A, Mitamura H, Mitsuoka T, Mazgalev T, Michelson EL, Dreifus LS. Interactive negative chronotropic actions of adenosine and verapamil on the canine sinus node in vivo. Prog Clin Biol Res. 1987; 230:235-52. PMID: 3588599.
      Citations:    
    114. Pelleg A, Mitsuoka T, Mazgalev T, Michelson EL. Vagal component in the chronotropic and dromotropic actions of adenosine and ATP. Prog Clin Biol Res. 1987; 230:375-84. PMID: 3588606.
      Citations:    
    115. Pelleg A, Mitamura H, Mitsuoka T, Michelson EL, Dreifus LS. Effects of adenosine and adenosine 5'-triphosphate on ventricular escape rhythm in the canine heart. J Am Coll Cardiol. 1986 Nov; 8(5):1145-51. PMID: 3760388.
      Citations:    
    116. David D, Michelson EL, Dreifus LS. The role of animal models in electrophysiologic studies of life-threatening arrhythmias. Pacing Clin Electrophysiol. 1986 Nov; 9(6):896-907. PMID: 2432491.
      Citations:    
    117. Mazgalev T, Dreifus LS, Michelson EL, Pelleg A. Effect of postganglionic vagal stimulation on the organization of atrioventricular nodal conduction in isolated rabbit heart tissue. Circulation. 1986 Oct; 74(4):869-80. PMID: 3757195.
      Citations:    
    118. Mazgalev T, Dreifus LS, Michelson EL, Pelleg A. Vagally induced hyperpolarization in atrioventricular node. Am J Physiol. 1986 Sep; 251(3 Pt 2):H631-43. PMID: 3752273.
      Citations:    
    119. Mazgalev T, Dreifus LS, Michelson EL, Pelleg A, Price R. Phasic effects of postganglionic vagal stimulation on atrioventricular nodal conduction. Am J Physiol. 1986 Sep; 251(3 Pt 2):H619-30. PMID: 3752272.
      Citations:    
    120. Frishman WH, Charlap S, Michelson EL. Calcium channel blockers in systemic hypertension. Am J Cardiol. 1986 Jul 01; 58(1):157-60. PMID: 3524178.
      Citations:    
    121. Iinuma H, Dreifus LS, Price R, Michelson EL. Influence of the site of stimulation on atrioventricular nodal refractory periods and the effect of verapamil. Am J Cardiol. 1986 May 01; 57(13):1167-74. PMID: 3706171.
      Citations:    
    122. Pelleg A, Mitamura H, Michelson EL, Dreifus LS. Evidence against prostaglandin mediation of the differential electrophysiologic effects of ATP versus adenosine in the canine heart. J Cardiovasc Pharmacol. 1986 May-Jun; 8(3):534-8. PMID: 2425169.
      Citations:    
    123. David D, Michelson EL, Naito M, Chen CC, Schaffenburg M, Dreifus LS. Diastolic 'locking' of the mitral valve: possible importance of diastolic myocardial properties. Circulation. 1986 May; 73(5):997-1005. PMID: 3698243.
      Citations:    
    124. Wetstein L, Mark R, Kaplinsky E, Kaplan A, Sauermelch C, Michelson EL. Histopathologic correlates of inducible ventricular tachycardia in two experimental canine models of myocardial infarction. Am J Med Sci. 1986 Apr; 291(4):222-31. PMID: 3706390.
      Citations:    
    125. Dreifus LS, Mitamura H, Rhauda A, Vail S, Michelson EL, Berkovits BV, Peterson DD, Figueroa WF. Effects of AV sequential versus asynchronous AV pacing on pulmonary hemodynamics. Pacing Clin Electrophysiol. 1986 Mar; 9(2):171-7. PMID: 2419865.
      Citations:    
    126. Moore EN, Spear JF, Michelson EL, Wetstein L. Evaluation of electrophysiologic factors modifying results of programmed electrical stimulation in animal preparations of myocardial infarction. Circulation. 1986 Feb; 73(2 Pt 2):II11-7. PMID: 3943171.
      Citations:    
    127. Wetstein L, Mark R, Kaplan A, Mitamura H, Sauermelch C, Michelson EL. Nonarrhythmogenicity of therapeutic cryothermic lesions of the myocardium. J Surg Res. 1985 Dec; 39(6):543-54. PMID: 4068693.
      Citations:    
    128. Wetstein L, Mark R, Kaplinsky E, Mitamura H, Kaplan A, Sauermelch C, Michelson EL. Histopathologic factors conducive to experimental ventricular tachycardia. Surgery. 1985 Sep; 98(3):532-9. PMID: 4035573.
      Citations:    
    129. Pelleg A, Mitamura H, Michelson EL. Evidence for vagal involvement in the electrophysiologic actions of exogenous adenosine and adenosine triphosphate in the canine heart. J Auton Pharmacol. 1985 Sep; 5(3):207-12. PMID: 4055818.
      Citations:    
    130. Mitamura H, Ohm OJ, Michelson EL, Sauermelch C, Dreifus LS. Importance of the pacing mode in the initiation of ventricular tachyarrhythmia in a canine model of chronic myocardial infarction. J Am Coll Cardiol. 1985 Jul; 6(1):99-103. PMID: 4008792.
      Citations:    
    131. Moore EN, Spear JF, Wetstein L, Michelson EL. Critical appraisal of programmed electrical stimulation for evaluating hearts prone to ventricular tachyarrhythmias. P R Health Sci J. 1985 Jun; 4(2):91-4. PMID: 3832153.
      Citations:    
    132. Wetstein L, Michelson EL, Spear JF, Moore EN. Propensity to develop ventricular tachyarrhythmias: differences in homogeneous versus heterogeneous myocardial infarcts. P R Health Sci J. 1985 Jun; 4(2):79-89. PMID: 3832152.
      Citations:    
    133. Frishman WH, Charlap S, Farnham DJ, Sawin HS, Michelson EL, Crawford MH, DiBianco R, Kostis JB, Zellner SR, Michie DD, et al. Combination propranolol and bepridil therapy in stable angina pectoris. Am J Cardiol. 1985 Mar 15; 55(7):43C-49C. PMID: 3883741.
      Citations:    
    134. Mazgalev T, Dreifus LS, Michelson E. Interaction of the input atrial excitatory waves and conduction through the atrioventricular node. I. Changes in the cellular electrical activity. Acta Physiol Pharmacol Bulg. 1985; 11(1):43-54. PMID: 4036651.
      Citations:    
    135. Michelson EL. Electrophysiology of experimental models of sudden death. Cardiovasc Clin. 1985; 15(3):29-40. PMID: 3914365.
      Citations:    
    136. Michelson EL, Medina RP. Introduction to clinical electrophysiologic studies. Cardiovasc Clin. 1985; 16(1):1-36. PMID: 3915708.
      Citations:    
    137. Saichin A, Dreifus LS, Michelson EL. Electrophysiologic studies of the AV conduction system and AV nodal arrhythmias. Cardiovasc Clin. 1985; 16(1):61-82. PMID: 3915716.
      Citations:    
    138. Mazgalev T, Dreifus LS, Ininuma H, Michelson EL. Effects of the site and timing of atrioventricular nodal input on atrioventricular conduction in the isolated perfused rabbit heart. Circulation. 1984 Oct; 70(4):748-59. PMID: 6478573.
      Citations:    
    139. Michelson EL, Dreifus LS. Present status of clinical electrophysiologic studies: introduction--what studies are necessary. Pacing Clin Electrophysiol. 1984 May; 7(3 Pt 1):421-31. PMID: 6204295.
      Citations:    
    140. Wetstein L, Michelson EL, Moore EN, Harken AH. Evaluation of arrhythmogenicity of surgically induced endocardial versus ischemic myocardial damage. J Thorac Cardiovasc Surg. 1984 Apr; 87(4):571-6. PMID: 6708577.
      Citations:    
    141. Mazgalev T, Dreifus LS, Michelson EL, Bianchi J. The role of the phase relation between the atrial excitatory waves in determining the functional refractory properties of the atrioventricular node. Acta Physiol Pharmacol Bulg. 1984; 10(2):53-63. PMID: 6485823.
      Citations:    
    142. David D, Kitchen JG, Michelson EL, Naito M, Sawin HS, Chen CC. R-wave amplitude responses to rapid atrial pacing: a marker for myocardial ischemia. Am Heart J. 1984 Jan; 107(1):53-61. PMID: 6691240.
      Citations:    
    143. Wetstein L, Michelson EL, Moore EN, Harken AH. Surgical therapy for ventricular tachyarrhythmias. Surg Gynecol Obstet. 1983 Nov; 157(5):487-96. PMID: 6356426.
      Citations:    
    144. Michelson EL, Frishman WH, Lewis JE, Edwards WT, Flanigan WJ, Bloomfield SS, Johnson BF, Lucas C, Freis ED, Finnerty FA, et al. Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension. Am J Med. 1983 Oct 17; 75(4A):68-80. PMID: 6356901.
      Citations:    
    145. Frishman WH, Michelson EL, Johnson BF, Poland MP. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension. Am J Med. 1983 Oct 17; 75(4A):54-67. PMID: 6356900.
      Citations:    
    146. Wallin JD, Wilson D, Winer N, Maronde RF, Michelson EL, Langford H, Maloy J, Poland M. Treatment of severe hypertension with labetalol compared with methyldopa and furosemide. Results of a long-term, double-blind, multicenter trial. Am J Med. 1983 Oct 17; 75(4A):87-94. PMID: 6356903.
      Citations:    
    147. Wilson DJ, Wallin JD, Vlachakis ND, Freis ED, Vidt DG, Michelson EL, Langford HG, Flamenbaum W, Poland MP. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies. Am J Med. 1983 Oct 17; 75(4A):95-102. PMID: 6139020.
      Citations:    
    148. Iinuma H, Dreifus LS, Mazgalev T, Price R, Michelson EL. Role of the perinodal region in atrioventricular nodal reentry: evidence in an isolated rabbit heart preparation. J Am Coll Cardiol. 1983 Sep; 2(3):465-73. PMID: 6875110.
      Citations:    
    149. Dreifus LS, Michelson EL. Contribution of the concept of dual pathways in the atrioventricular node to the understanding of supraventricular tachycardias and conduction abnormalities. Pacing Clin Electrophysiol. 1983 Sep; 6(5 Pt 2):1084-93. PMID: 6195629.
      Citations:    
    150. Naito M, David D, Michelson EL, Schaffenburg M, Dreifus LS. The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model. Am Heart J. 1983 Aug; 106(2):284-91. PMID: 6869209.
      Citations:    
    151. Spear JF, Michelson EL, Moore EN. Reduced space constant in slowly conducting regions of chronically infarcted canine myocardium. Circ Res. 1983 Aug; 53(2):176-85. PMID: 6883644.
      Citations:    
    152. Spear JF, Michelson EL, Moore EN. Cellular electrophysiologic characteristics of chronically infarcted myocardium in dogs susceptible to sustained ventricular tachyarrhythmias. J Am Coll Cardiol. 1983 Apr; 1(4):1099-110. PMID: 6833648.
      Citations:    
    153. Iinuma H, Dreifus LS, Bianchi J, Michelson EL. Supernormal response and conduction in depressed isolated canine ventricular muscle exposed to high potassium concentration. J Am Coll Cardiol. 1983 Mar; 1(3):830-9. PMID: 6186714.
      Citations:    
    154. Satake S, Bianchi J, Dreifus LS, Watanabe Y, Michelson EL. Tachycardia and apparent sino-atrial block due to concealed sinus node re-entry. Pacing Clin Electrophysiol. 1983 Mar; 6(2 Pt 1):229-37. PMID: 6189061.
      Citations:    
    155. David D, Michelson EL, Naito M, Chen CC, Schaffenburg M, Dreifus LS. Diastolic "locking" of the mitral valve: the importance of atrial systole and intraventricular volume. Circulation. 1983 Mar; 67(3):640-5. PMID: 6821907.
      Citations:    
    156. Naito M, Dreifus LS, David D, Michelson EL, Mardelli TJ, Kmetzo JJ. Reevaluation of the role of atrial systole to cardiac hemodynamics: evidence for pulmonary venous regurgitation during abnormal atrioventricular sequencing. Am Heart J. 1983 Feb; 105(2):295-302. PMID: 6823811.
      Citations:    
    157. Dreifus LS, Michelson EL, Kaplinsky E. Bradyarrhythmias: clinical significance and management. J Am Coll Cardiol. 1983 Jan; 1(1):327-38. PMID: 6826942.
      Citations:    
    158. Panidis I, Dreifus LS, Michelson EL. Hemodynamic effects of cardiac pacing. Cardiovasc Clin. 1983; 14(2):1-11. PMID: 6357439.
      Citations:    
    159. Mazgalev T, Dreifus LS, Bianchi J, Michelson EL. Atrioventricular nodal conduction during atrial fibrillation in rabbit heart. Am J Physiol. 1982 Nov; 243(5):H754-60. PMID: 7137368.
      Citations:    
    160. David D, Michelson EL, Naito M, Schaffenburg M, Dreifus LS. Increased R-wave amplitude induced by acute myocardial ischemia in the dog: a predictor of malignant ventricular arrhythmias. Am J Cardiol. 1982 Oct; 50(4):844-8. PMID: 7124644.
      Citations:    
    161. Wetstein L, Michelson EL, Simson MB, Moore EN, Harken AH. Initiation of ventricular tachyarrhythmia with programmed stimulation: sensitivity and specificity in an experimental canine model. Surgery. 1982 Aug; 92(2):206-11. PMID: 7101123.
      Citations:    
    162. Soffer J, Dreifus LS, Michelson EL. Polymorphous ventricular tachycardia associated with normal and long Q-T intervals. Am J Cardiol. 1982 Jun; 49(8):2021-9. PMID: 7081082.
      Citations:    
    163. Wetstein L, Michelson EL, Simson MB, Moore EN, Harken AH. Increased normoxic-to-ischemic tissue borderzone as the cause for reentrant ventricular tachyarrhythmias. J Surg Res. 1982 May; 32(5):526-34. PMID: 7087439.
      Citations:    
    164. Naito M, Michelson EL, Kaplinsky E, Dreifus LS, David D, Blenko TM. Role of early cycle ventricular extrasystoles in initiation of ventricular tachycardia and fibrillation: evaluation of the R on T phenomenon during acute ischemia in a canine model. Am J Cardiol. 1982 Feb 01; 49(2):317-22. PMID: 6174040.
      Citations:    
    165. David D, Naito M, Michelson E, Watanabe Y, Chen CC, Morganroth J, Shaffenburg M, Blenko T. Intramyocardial conduction: a major determinant of R-wave amplitude during acute myocardial ischemia. Circulation. 1982 Jan; 65(1):161-7. PMID: 7053277.
      Citations:    
    166. Spear JF, Michelson EL, Moore EN. The use of animal models in the study of the electrophysiology of sudden coronary deaths. Ann N Y Acad Sci. 1982; 382:78-89. PMID: 7044247.
      Citations:    
    167. Michelson EL. Recent advances in antiarrhythmic drug research: studies in chronic canine myocardial infarction-ventricular tachyarrhythmia models. Pacing Clin Electrophysiol. 1982 Jan; 5(1):90-9. PMID: 6181478.
      Citations:    
    168. Michelson EL. Aspirin and perioperative blood loss. JAMA. 1981 Dec 18; 246(24):2808. PMID: 7310972.
      Citations:    
    169. Michelson EL. Canine models for ventricular tachyarrhythmia. Ann Intern Med. 1981 Nov; 95(5):648-9. PMID: 7294556.
      Citations:    
    170. Michelson EL, Spear JF, Moore EN. Further electrophysiologic and anatomic correlates in a canine model of chronic myocardial infarction susceptible to the initiation of sustained ventricular tachyarrhythmias. Anat Rec. 1981 Sep; 201(1):55-65. PMID: 7305023.
      Citations:    
    171. Simson MB, Euler D, Michelson EL, Falcone RA, Spear JF, Moore EN. Detection of delayed ventricular activation on the body surface in dogs. Am J Physiol. 1981 Sep; 241(3):H363-9. PMID: 7282945.
      Citations:    
    172. David D, Naito M, Michelson EL, Morganroth J, Mardelli TJ, Blenko T. Atrial alternans: experimental echocardiographic and hemodynamic demonstration during programmed pacing. Am J Cardiol. 1981 Sep; 48(3):468-72. PMID: 7270453.
      Citations:    
    173. Mazgalev T, Dreifus LS, Bianchi J, Michelson EL. The mechanism of AV junctional reentry: role of the atrionodal junction. Anat Rec. 1981 Sep; 201(1):179-88. PMID: 7305019.
      Citations:    
    174. Naito M, Michelson EL, Kmetzo JJ, Kaplinsky E, Dreifus LS. Failure of antiarrhythmic drugs to affect epicardial delay during acute experimental coronary artery occlusion and reperfusion: correlation with lack of antiarrhythmic efficacy. J Pharmacol Exp Ther. 1981 Aug; 218(2):475-80. PMID: 7252847.
      Citations:    
    175. David D, Naito M, Chen CC, Michelson EL, Morganroth J, Schaffenburg M. R-wave amplitude variations during acute experimental myocardial ischemia: an inadequate index for changes in intracardiac volume. Circulation. 1981 Jun; 63(6):1364-71. PMID: 7226482.
      Citations:    
    176. Michelson EL, Spear JF, Moore EN. Effects of procainamide on strength-interval relations in normal and chronically infarcted canine myocardium. Am J Cardiol. 1981 Jun; 47(6):1223-32. PMID: 7234696.
      Citations:    
    177. Michelson EL, Spear JF, Moore EN. Strength-interval relations in a chronic canine model of myocardial infarction. Implications for the interpretation of electrophysiologic studies. Circulation. 1981 May; 63(5):1158-65. PMID: 7471377.
      Citations:    
    178. Michelson EL, Spear JF, Moore EN. Initiation of sustained ventricular tachyarrhythmias in a canine model of chronic myocardial infarction: importance of the site of stimulation. Circulation. 1981 Apr; 63(4):776-84. PMID: 7471333.
      Citations:    
    179. Balke CW, Kaplinsky E, Michelson EL, Naito M, Dreifus LS. Reperfusion ventricular tachyarrhythmias: correlation with antecedent coronary artery occlusion tachyarrhythmias and duration of myocardial ischemia. Am Heart J. 1981 Apr; 101(4):449-56. PMID: 7211674.
      Citations:    
    180. Katz AS, Michelson EL, Stawicki J, Holford FD. Cardiac arrhythmias. Frequency during fiberoptic bronchoscopy and correlation with hypoxemia. Arch Intern Med. 1981 Apr; 141(5):603-6. PMID: 7224740.
      Citations:    
    181. Kaplinsky E, Ogawa S, Michelson EL, Dreifus LS. Instantaneous and delayed ventricular arrhythmias after reperfusion of acutely ischemic myocardium: evidence for multiple mechanisms. Circulation. 1981 Feb; 63(2):333-40. PMID: 7449056.
      Citations:    
    182. Naito M, Michelson EL, Kmetzo JJ, Kaplinsky E, Dreifus LS. Failure of antiarrhythmic drugs to prevent experimental reperfusion ventricular fibrillation. Circulation. 1981 Jan; 63(1):70-9. PMID: 7438409.
      Citations:    
    183. Naito M, Dreifus LS, Mardelli TJ, Chen CC, David D, Michelson EL, Marcy V, Morganroth J. Echocardiographic features of atrioventricular and ventriculoatrial conduction. Am J Cardiol. 1980 Oct; 46(4):625-33. PMID: 7416022.
      Citations:    
    184. Zeldis SM, Levine BJ, Michelson EL, Morganroth J. Cardiovascular complaints. Correlation with cardiac arrhythmias on 24-hour electrocardiographic monitoring. Chest. 1980 Sep; 78(3):456-61. PMID: 7418465.
      Citations:    
    185. Farshidi A, Michelson EL, Greenspan AM, Spielman SR, Horowitz LN, Josephson ME. Repetitive responses to ventricular extrastimuli: incidence, mechanism, and significance. Am Heart J. 1980 Jul; 100(1):59-68. PMID: 7386366.
      Citations:    
    186. Follansbee WP, Michelson EL, Morganroth J. Nonsustained ventricular tachycardia in ambulatory patients: characteristics and association with sudden cardiac death. Ann Intern Med. 1980 Jun; 92(6):741-7. PMID: 7387016.
      Citations:    
    187. Michelson EL, Morganroth J. Spontaneous variability of complex ventricular arrhythmias detected by long-term electrocardiographic recording. Circulation. 1980 Apr; 61(4):690-5. PMID: 7357710.
      Citations:    
    188. Michelson EL, Spear JF, Moore EN. Electrophysiologic and anatomic correlates of sustained ventricular tachyarrhythmias in a model of chronic myocardial infarction. Am J Cardiol. 1980 Mar; 45(3):583-90. PMID: 7355755.
      Citations:    
    189. Michelson EL, Dreifus LS. The diagnosis of arrhythmias: the relative roles of the ECG, Holter monitoring, exercise stress testing, and electrophysiologic studies. Med Times. 1980 Jan; 108(1):35-41. PMID: 7374398.
      Citations:    
    190. Dreifus LS, Michelson EL. The management of arrhythmias. Med Times. 1980 Jan; 108(1):29-30. PMID: 7374396.
      Citations:    
    191. Morganroth J, Michelson E. The contributions of ambulatory ECG. Geriatrics. 1979 Dec; 34(12):60-8. PMID: 499818.
      Citations:    
    192. Morganroth J, Pearlman AS, Dunkman WB, Horowitz LN, Josephson ME, Michelson EL. Ethmozin: a new antiarrhythmic agent developed in the USSR. Efficacy and tolerance. Am Heart J. 1979 Nov; 98(5):621-8. PMID: 495408.
      Citations:    
    193. Michelson EL, Morganroth J, Nichols CW, MacVaugh H. Retinal arteriolar changes as an indicator of coronary artery disease. Arch Intern Med. 1979 Oct; 139(10):1139-41. PMID: 485746.
      Citations:    
    194. Michelson EL, Morganroth J. Spontaneous variability in arrhythmia frequency. Am Heart J. 1979 Jun; 97(6):815. PMID: 433760.
      Citations:    
    195. Michelson EL, Spielman SR, Greenspan AM, Farshidi A, Horowitz LN, Josephson ME. Electrophysiologic study of the left ventricle: indications and safety. Chest. 1979 May; 75(5):592-6. PMID: 436488.
      Citations:    
    196. Michelson EL, Morganroth J, MacVaugh H. Postoperative arrhythmias after coronary artery and cardiac valvular surgery detected by long-term electrocardiographic monitoring. Am Heart J. 1979 Apr; 97(4):442-8. PMID: 311579.
      Citations:    
    197. Josephson ME, Horowitz LN, Farshidi A, Spielman SR, Michelson EL, Greenspan AM. Recurrent sustained ventricular tachycardia. 4. Pleomorphism. Circulation. 1979 Mar; 59(3):459-68. PMID: 761327.
      Citations:    
    198. Michelson EL, Morganroth J, Spear JF, Kastor JA, Josephson ME. Fixed coupling: different mechanisms revealed by exercise-induced changes in cycle length. Circulation. 1978 Dec; 58(6):1002-9. PMID: 709757.
      Citations:    
    199. Horowitz LN, Josephson ME, Farshidi A, Spielman SR, Michelson EL, Greenspan AM. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens. Circulation. 1978 Dec; 58(6):986-97. PMID: 709782.
      Citations:    
    200. Morganroth J, Michelson EL, Horowitz LN, Josephson ME, Pearlman AS, Dunkman WB. Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency. Circulation. 1978 Sep; 58(3 Pt 1):408-14. PMID: 679430.
      Citations:    
    201. Josephson ME, Horowitz LN, Farshidi A, Spielman SR, Michelson EL, Greenspan AM. Sustained ventricular tachycardia: evidence for protected localized reentry. Am J Cardiol. 1978 Sep; 42(3):416-24. PMID: 687393.
      Citations:    
    202. Zeldis SM, Morganroth J, Horowitz LN, Michelson EL, Josephson ME, Lozner EC, MacVaugh H, Kastor JA. Fascicular conduction distrubances after coronary bypass surgery. Am J Cardiol. 1978 May 01; 41(5):860-4. PMID: 306190.
      Citations:    
    203. Spielman SR, Michelson EL, Horowitz LN, Spear JF, Moore EN. The limitations of epicardial mapping as a guide to the surgical therapy of ventricular tachycardia. Circulation. 1978 Apr; 57(4):666-70. PMID: 630673.
      Citations:    
    204. Spear JF, Michelson EL, Spielman SR, Moore EN. The origin of ventricular arrhythmias 24 hours following experimental anterior septal coronary artery occlusion. Circulation. 1977 Jun; 55(6):844-52. PMID: 858183.
      Citations:    
    205. Michelson E. Treatment of anaphylaxis. N Engl J Med. 1968 May 23; 278(21):1181. PMID: 5646728.
      Citations:    
    206. Michelson E. Anaphylactic reaction to dextrans. N Engl J Med. 1968 Mar 07; 278(10):552. PMID: 5637240.
      Citations:    
    Michelson's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (449)
    Explore
    _
    Co-Authors (8)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _